UBS Group AG

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Back to SRPT Full portfolio

Position in SRPT

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$48,578,306

+$4,275,062 QoQ

Shares Held

2,232,459

+8.4% QoQ

Ownership

2.11%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 97.40832866359472.ToString("F0")% Shared 0.ToString("F0")% None 2.591671336405282.ToString("F0")%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Derivatives in SRPT

reported options exposure · as of Dec 31, 2025

CallValue

$129,120

CallShares

6,000

PutValue

$322,800

PutShares

15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. SRPT ranks #42 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

All Filings in SRPT

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$48,578,306	2,232,459	+14783.1%	Shares	Defined	2026-05-05
2025-12-31	$322,800	15,000	+150.0%	Put	Defined	2026-01-29
2025-12-31	$129,120	6,000	-99.7%	Call	Defined	2026-01-29
2025-12-31	$44,303,244	2,058,701	+3.4%	Shares	Defined	2026-01-29
2025-09-30	$38,357,088	1,990,508	+297.2%	Shares	Defined	2025-11-13
2025-06-30	$8,568,534	501,084	-65.4%	Shares	Defined	2025-08-14
2025-03-31	$92,312,947	1,446,458	-2.3%	Shares	Defined	2025-05-13
2024-12-31	$179,952,955	1,479,998	+306.4%	Shares	Defined	2025-02-14
2024-09-30	$45,481,439	364,172	+3.8%	Shares	Defined	2024-11-14
2024-06-30	$55,420,712	350,764	+425.9%	Shares	Defined	2024-08-14
2024-06-30	$10,538,600	66,700	+455.8%	Call	Defined	2024-08-14
2024-06-30	$1,896,000	12,000	-95.7%	Put	Defined	2024-08-14
2024-03-31	$35,885,016	277,190	+0.3%	Shares	Defined	2024-05-13
2023-12-31	$26,641,292	276,276	+2839.1%	Shares	Defined	2024-02-09
2023-09-30	$1,139,468	9,400	-95.9%	Put	Defined	2023-11-09
2023-09-30	$27,622,521	227,871	+5.3%	Shares	Defined	2023-11-09
2023-06-30	$24,775,255	216,340	+11.3%	Shares	Defined	2023-08-11
2023-03-31	$26,797,182	194,422	+32303.7%	Shares	Defined	2023-05-12
2022-12-31	$77,748	600	-99.6%	Call	Defined	2023-02-08
2022-12-31	$21,080,073	162,680	+130.0%	Shares	Defined	2023-02-08
2022-09-30	$7,819,377	70,738	+135.0%	Shares	Defined	2022-11-10
2022-09-30	$3,327,254	30,100	+4916.7%	Call	Defined	2022-11-10
2022-06-30	$44,976	600	-99.5%	Call	Defined	2022-08-10
2022-06-30	$8,765,671	116,938	-23.5%	Shares	Defined	2022-08-10
2022-03-31	$11,942,438	152,873	+144.0%	Shares	Defined	2022-05-16
2021-12-31	$5,641,091	62,644	+34.1%	Shares	Defined	2022-02-14
2021-09-30	$4,321,682	46,731	+37.7%	Shares	Defined	2021-11-15
2021-06-30	$2,638,106	33,935	-61.1%	Shares	Defined	2021-08-13
2021-03-31	$6,499,014	87,200	+21.5%	Shares	Defined	2021-05-12
2020-12-31	$12,232,656	71,750	+7.3%	Shares	Defined	2021-02-11
2020-09-30	$9,388,446	66,855	+452.5%	Shares	Defined	2020-11-12
2020-06-30	$1,940,114	12,100	-81.3%	Call	Defined	2020-07-31
2020-06-30	$10,400,453	64,865	-22.5%	Shares	Defined	2020-07-31
2020-03-31	$8,184,010	83,664	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.